Physician

Mitchell Andrew Romito, MD

According to 2025 Medicare claims, Mitchell Romito, MD (NPI: 1063918498) practices ophthalmology in the Lima, OH market, with the plurality of this provider's patient population coming from Allen, OH. This provider's primary affiliated billing organization is PAJKA EYE CENTER INC (NPI: 1831167097; TIN: 341146550) and primary practice location at 45805-2764.

Romito's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 984 traditional Medicare patients, billed 10,530 HCPCS/CPT codes, and received $401,249 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 4,847 prescription claims across 1,243 beneficiaries totaling $222,647 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 2 records totaling $328. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $4,153 to $222,647. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$201K$401K2022 Medicare payment: $115,423 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $298,899 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $401,249 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
20223323,257$115,423
20236847,888$298,899
202498410,530$401,249

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$111K$223K2018 Drug cost: $4,153 (USD; Tot_Drug_Cst)2019 Drug cost: $2,750 (USD; Tot_Drug_Cst)2020 Drug cost: $178 (USD; Tot_Drug_Cst)2022 Drug cost: $39,821 (USD; Tot_Drug_Cst)2023 Drug cost: $161,189 (USD; Tot_Drug_Cst)2024 Drug cost: $222,647 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/R21$4,153
20192155$2,750
20201117$178
2021N/RN/RN/R
2022250559$39,821
20237412,059$161,189
20241,2434,847$222,647

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system268270$73
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more425632$59
66984Removal of cataract with insertion of prosthetic lens2886,784$29
92136Measurement of corneal curvature and depth of eye339545$26
92133Imaging of optic nerve313333$21

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate93635,910$53,750
RestasisCyclosporine321,380$28,645
MoxifloxacinMoxifloxacin Hcl63610,721$26,068
XiidraLifitegrast11750$17,717
LumiganBimatoprost501,725$16,584

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$328RxSight Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Mitchell Andrew Romito, MD?

Tedicare shows public-source Medicare data for Mitchell Andrew Romito, MD (NPI 1063918498), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mitchell Andrew Romito, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mitchell Andrew Romito, MD?

Mitchell Andrew Romito, MD is linked to PAJKA EYE CENTER INC (billing NPI 1831167097) in the available physician profile data.

Does Mitchell Andrew Romito, MD have Open Payments data?

Mitchell Andrew Romito, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.